Early Outpatient Treatment for Covid-19: The Evidence
The Epoch Times,
The evidence accumulated very early on in the pandemic that the use of sequenced multi-drug therapeutics (SMDT) under physician…
Could controversial drug benefit COVID patients after all? Some N.J. docs say yes.
NJ.com,
No drug has been politicized quite like hydroxychloroquine. Former President Donald Trump touted the anti-malaria medication as…
Hackensack Meridian’s John Theurer Cancer Center (JTCC) Observational Study Suggests Role for Hydroxycholorquine as Outpatient Treatment for COVID-19 Infection
Newswise,
– Hackensack, NJ – Researchers from Hackensack Meridian Health John Theurer Cancer Center (JTCC), a member of the Georgetown…
Hackensack Meridian’s John Theurer Cancer Center (JTCC) Observational Study Suggests Role for Hydroxycholorquine as Outpatient Treatment for COVID-19 Infection | sciencenewsnet.in
Sciencenewsnet.in,
Post Views: 1 January 19, 2021 Hackensack, NJResearchers from Hackensack MeridianHealthJohn Theurer Cancer Center (JTCC)…